Abstract | OBJECTIVES: METHODS: To determine the effects of imidazole on melanoma cell migration, B16 cells were treated with imidazole at various concentrations, and the migration was measured using a scratch migration assay. KEY FINDINGS:
Imidazole did not exhibit cytotoxic effects on B16 cells at a concentration below 100 microm. The anti-migratory activity of imidazole was determined by the scratch migration assay. Our results showed that imidazole significantly inhibits B16 cell migration. It is known that the Wnt/ beta-catenin signalling pathway regulates the progression of melanocytic tumours and determines the prognosis in cutaneous melanomas. Western blot analysis demonstrated that imidazole increases phosphorylation of beta-catenin and subsequent degradation of beta-catenin. Moreover, inhibition of melanoma cell migration by imidazole was restored by MG132, a proteasome inhibitor, via inhibition of beta-catenin degradation. CONCLUSIONS:
|
Authors | Yun-Mi Jeong, Hailan Li, Su Yeon Kim, Hye-Young Yun, Kwang Jin Baek, Nyoun Soo Kwon, Dong-Seok Kim |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 62
Issue 4
Pg. 491-6
(Apr 2010)
ISSN: 2042-7158 [Electronic] England |
PMID | 20604839
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Imidazoles
- Leupeptins
- beta Catenin
- imidazole
- benzyloxycarbonylleucyl-leucyl-leucine aldehyde
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Blotting, Western
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Imidazoles
(pharmacology, therapeutic use)
- Leupeptins
(pharmacology)
- Melanoma
(drug therapy, metabolism)
- Mice
- Phosphorylation
- Signal Transduction
(drug effects)
- beta Catenin
(metabolism)
|